Lite Strategy, Inc. (LITS) Insider Trading Activity

NASDAQ$1.11+0.07 (6.73%)
Market Cap
$31.62M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
270 of 849
Rank in Industry
152 of 491

LITS Insider Trading Activity

LITS Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$141,864
3
75
Sells
$946,137
1
25

Related Transactions

Flynn James Pdirector
3
$141,864
0
$0
$141,864
Schornstein Alexander10 percent owner
0
$0
1
$946,137
$-946,137

About Lite Strategy, Inc.

Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients. This entity, which was previously known as MEI Pharma, Inc., officially changed its designation to Lite Strategy, Inc. in September 2025. The company was established in 2000 and has its principal operations located in San Diego, California.

Insider Activity of Lite Strategy, Inc.

Over the last 12 months, insiders at Lite Strategy, Inc. have bought $141,864 and sold $946,137 worth of Lite Strategy, Inc. stock.

On average, over the past 5 years, insiders at Lite Strategy, Inc. have bought $77,207 and sold $946,137 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Flynn James P (director) — $141,864.

The last purchase of 25,000 shares for transaction amount of $21,388 was made by Flynn James P (director) on 2026‑06‑24.

List of Insider Buy and Sell Transactions, Lite Strategy, Inc.

2026-06-24PurchaseFlynn James Pdirector
25,000
0.0706%
$0.86
$21,388
+17.41%
2025-12-19PurchaseFlynn James Pdirector
70,000
0.1852%
$1.40
$97,699
-20.98%
2025-12-18SaleSchornstein Alexander10 percent owner
690,611
1.7935%
$1.37
$946,137
-16.30%
2025-11-19PurchaseFlynn James Pdirector
12,100
0.0432%
$1.88
$22,777
-35.96%
2025-07-23PurchaseGlover Nicholasdirector
1,000
0.0114%
$6.00
$6,000
2025-07-22PurchaseGlover Nicholasdirector
1,000
0.0124%
$6.55
$6,550
2008-06-26PurchaseForza Capital Management, L.L.C.10 percent owner
300
0.0002%
$0.38
$114
2008-06-13PurchaseForza Capital Management, L.L.C.10 percent owner
1,000
0.0008%
$0.40
$400
2008-05-27PurchaseForza Capital Management, L.L.C.10 percent owner
2,500
0.0024%
$0.51
$1,275
2008-05-22PurchaseForza Capital Management, L.L.C.10 percent owner
10,000
0.0097%
$0.51
$5,100
2008-05-21PurchaseForza Capital Management, L.L.C.10 percent owner
1,650
0.0017%
$0.53
$875
2008-05-19PurchaseForza Capital Management, L.L.C.10 percent owner
10,000
0.0083%
$0.44
$4,400
2008-05-15PurchaseForza Capital Management, L.L.C.10 percent owner
5,000
0.0042%
$0.44
$2,200
2008-05-09PurchaseForza Capital Management, L.L.C.director
1,000
0.0009%
$0.47
$470
2008-05-07PurchaseForza Capital Management, L.L.C.10 percent owner
4,000
0.0033%
$0.44
$1,760
2008-05-06PurchaseForza Capital Management, L.L.C.10 percent owner
45,000
0.0358%
$0.42
$18,873
2008-04-21PurchaseForza Capital Management, L.L.C.10 percent owner
3,000
0.003%
$0.53
$1,575
2008-04-18PurchaseForza Capital Management, L.L.C.10 percent owner
6,000
0.0058%
$0.51
$3,050
2008-04-17PurchaseForza Capital Management, L.L.C.10 percent owner
4,000
0.0039%
$0.52
$2,060
2008-04-16PurchaseForza Capital Management, L.L.C.10 percent owner
3,500
0.0035%
$0.52
$1,825
Total: 106
*Gray background shows transactions not older than one year

LITS Institutional Investors: Active Positions

Increased Positions20+31.75%3M+32.92%
Decreased Positions26-41.27%5M-51.43%
New Positions9New952,320New
Sold Out Positions16Sold Out3MSold Out
Total Postitions57-9.52%8M-18.51%

LITS Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

No data is available at this moment.

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.